vs

Side-by-side financial comparison of Editas Medicine, Inc. (EDIT) and Legacy Education Inc. (LGCY). Click either name above to swap in a different company.

Editas Medicine, Inc. is the larger business by last-quarter revenue ($24.7M vs $19.2M, roughly 1.3× Legacy Education Inc.). Legacy Education Inc. runs the higher net margin — 10.6% vs -22.7%, a 33.4% gap on every dollar of revenue. On growth, Legacy Education Inc. posted the faster year-over-year revenue change (40.7% vs -19.2%). Legacy Education Inc. produced more free cash flow last quarter ($512.7K vs $-36.4M).

Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

Legacy Education Inc. is a professional educational service provider focused on financial literacy, real estate investment, entrepreneurship, and personal wealth management training programs. It mainly serves individual learners across North America, Europe and select Asia-Pacific markets, offering both in-person workshops and online digital courses to help users build practical financial and business skills.

EDIT vs LGCY — Head-to-Head

Bigger by revenue
EDIT
EDIT
1.3× larger
EDIT
$24.7M
$19.2M
LGCY
Growing faster (revenue YoY)
LGCY
LGCY
+59.9% gap
LGCY
40.7%
-19.2%
EDIT
Higher net margin
LGCY
LGCY
33.4% more per $
LGCY
10.6%
-22.7%
EDIT
More free cash flow
LGCY
LGCY
$37.0M more FCF
LGCY
$512.7K
$-36.4M
EDIT

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
EDIT
EDIT
LGCY
LGCY
Revenue
$24.7M
$19.2M
Net Profit
$-5.6M
$2.0M
Gross Margin
Operating Margin
-31.3%
13.3%
Net Margin
-22.7%
10.6%
Revenue YoY
-19.2%
40.7%
Net Profit YoY
87.6%
46.0%
EPS (diluted)
$0.03
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EDIT
EDIT
LGCY
LGCY
Q4 25
$24.7M
$19.2M
Q3 25
$7.5M
$19.4M
Q2 25
$3.6M
$18.0M
Q1 25
$4.7M
$18.6M
Q4 24
$30.6M
$13.6M
Q3 24
$61.0K
$14.0M
Q2 24
$513.0K
Q1 24
$1.1M
Net Profit
EDIT
EDIT
LGCY
LGCY
Q4 25
$-5.6M
$2.0M
Q3 25
$-25.1M
$2.2M
Q2 25
$-53.2M
$1.2M
Q1 25
$-76.1M
$2.8M
Q4 24
$-45.4M
$1.4M
Q3 24
$-62.1M
$2.1M
Q2 24
$-67.6M
Q1 24
$-62.0M
Operating Margin
EDIT
EDIT
LGCY
LGCY
Q4 25
-31.3%
13.3%
Q3 25
-325.4%
13.9%
Q2 25
-1440.6%
11.1%
Q1 25
-1635.1%
19.7%
Q4 24
-152.2%
12.2%
Q3 24
-107649.2%
19.1%
Q2 24
-14016.2%
Q1 24
-5902.3%
Net Margin
EDIT
EDIT
LGCY
LGCY
Q4 25
-22.7%
10.6%
Q3 25
-333.0%
11.3%
Q2 25
-1487.8%
6.8%
Q1 25
-1633.5%
15.2%
Q4 24
-148.3%
10.3%
Q3 24
-101870.5%
14.9%
Q2 24
-13178.8%
Q1 24
-5458.1%
EPS (diluted)
EDIT
EDIT
LGCY
LGCY
Q4 25
$0.03
$0.15
Q3 25
$-0.28
$0.16
Q2 25
$-0.63
$0.07
Q1 25
$-0.92
$0.21
Q4 24
$-0.55
$0.10
Q3 24
$-0.75
$0.21
Q2 24
$-0.82
Q1 24
$-0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EDIT
EDIT
LGCY
LGCY
Cash + ST InvestmentsLiquidity on hand
$146.6M
$21.1M
Total DebtLower is stronger
$660.3K
Stockholders' EquityBook value
$27.3M
$46.1M
Total Assets
$186.5M
$73.1M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EDIT
EDIT
LGCY
LGCY
Q4 25
$146.6M
$21.1M
Q3 25
$165.6M
$20.6M
Q2 25
$178.5M
$20.3M
Q1 25
$221.0M
$17.3M
Q4 24
$269.9M
$16.9M
Q3 24
$265.1M
$21.5M
Q2 24
$279.1M
Q1 24
$296.2M
Total Debt
EDIT
EDIT
LGCY
LGCY
Q4 25
$660.3K
Q3 25
$776.9K
Q2 25
$1.4M
Q1 25
$1.0M
Q4 24
$57.4M
$1.1M
Q3 24
$758.2K
Q2 24
Q1 24
Stockholders' Equity
EDIT
EDIT
LGCY
LGCY
Q4 25
$27.3M
$46.1M
Q3 25
$13.5M
$43.7M
Q2 25
$19.2M
$41.0M
Q1 25
$62.4M
$39.3M
Q4 24
$134.3M
$36.4M
Q3 24
$175.6M
$32.6M
Q2 24
$232.0M
Q1 24
$294.4M
Total Assets
EDIT
EDIT
LGCY
LGCY
Q4 25
$186.5M
$73.1M
Q3 25
$201.8M
$72.1M
Q2 25
$210.6M
$69.2M
Q1 25
$263.7M
$67.1M
Q4 24
$341.6M
$62.1M
Q3 24
$327.6M
$50.6M
Q2 24
$384.8M
Q1 24
$440.3M
Debt / Equity
EDIT
EDIT
LGCY
LGCY
Q4 25
0.01×
Q3 25
0.02×
Q2 25
0.03×
Q1 25
0.03×
Q4 24
0.43×
0.03×
Q3 24
0.02×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EDIT
EDIT
LGCY
LGCY
Operating Cash FlowLast quarter
$-36.4M
$1.1M
Free Cash FlowOCF − Capex
$-36.4M
$512.7K
FCF MarginFCF / Revenue
-147.3%
2.7%
Capex IntensityCapex / Revenue
0.2%
2.8%
Cash ConversionOCF / Net Profit
0.52×
TTM Free Cash FlowTrailing 4 quarters
$4.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EDIT
EDIT
LGCY
LGCY
Q4 25
$-36.4M
$1.1M
Q3 25
$-30.8M
$1.1M
Q2 25
$-50.2M
$3.0M
Q1 25
$-47.8M
$918.7K
Q4 24
$-50.8M
$659.0K
Q3 24
$-52.6M
$3.2M
Q2 24
$-57.1M
Q1 24
$-49.9M
Free Cash Flow
EDIT
EDIT
LGCY
LGCY
Q4 25
$-36.4M
$512.7K
Q3 25
$-31.3M
$809.7K
Q2 25
$2.9M
Q1 25
$-47.9M
$596.6K
Q4 24
$-51.3M
$466.8K
Q3 24
$-55.5M
$2.9M
Q2 24
$-60.6M
Q1 24
$-51.7M
FCF Margin
EDIT
EDIT
LGCY
LGCY
Q4 25
-147.3%
2.7%
Q3 25
-414.6%
4.2%
Q2 25
16.2%
Q1 25
-1028.6%
3.2%
Q4 24
-167.6%
3.4%
Q3 24
-90998.4%
21.1%
Q2 24
-11804.3%
Q1 24
-4558.9%
Capex Intensity
EDIT
EDIT
LGCY
LGCY
Q4 25
0.2%
2.8%
Q3 25
5.7%
1.3%
Q2 25
0.0%
0.5%
Q1 25
2.4%
1.7%
Q4 24
1.8%
1.4%
Q3 24
4788.5%
1.7%
Q2 24
681.1%
Q1 24
164.8%
Cash Conversion
EDIT
EDIT
LGCY
LGCY
Q4 25
0.52×
Q3 25
0.48×
Q2 25
2.45×
Q1 25
0.33×
Q4 24
0.47×
Q3 24
1.52×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons